HOME >> BIOLOGY >> NEWS
New egg-free flu vaccine called promising for those with egg allergy

SAN DIEGO, April 2 - Austrian researchers have developed a unique flu vaccine that is made without egg proteins, which can trigger rare but potentially fatal allergic reactions in some people. "The development represents the newest and most successful approach to influenza vaccine development in 50 years," says Otfried Kistner, Ph.D.

Kistner, a virologist with Baxter Hyland Immuno in Orth/Donau, Austria, and director of the research project, described the vaccine today at the 221st national meeting of the American Chemical Society, the world's largest scientific society.

Although at least two other manufacturers are testing egg-free flu vaccines, Kistner notes that only his company is using cells that have previously been accepted by regulatory authorities in the United States and Europe for human vaccine production.

According to the Austrian scientists, their new manufacturing technique is faster than methods that require chicken eggs, which can be in short supply during a large outbreak. As a result, the technique is expected to lessen the likelihood of flu vaccine shortages like those in the United States last year.

Phase I, II and III clinical trials were done in the United Kingdom, Austria and Poland with more than 2,500 volunteers. They were divided into two age groups: 18-59, and 60 and above. The studies showed that the new vaccine was effective in inducing specific antibodies against influenza, an indication that the vaccine will protect against infection.

"This does not mean that (conventional) vaccines are bad," says Kistner. "The benefit of vaccination is much greater than the risk of allergic reaction. The point of our vaccine is to improve it and minimize the risks which may appear."

Among the older patients who received the new vaccine, significantly fewer adverse effects were observed compared to those who received conventional vaccines. In the younger group, no significant differ
'"/>

Contact: Charmayne Marsh
202-872-4445
American Chemical Society
25-Mar-2001


Page: 1 2 3

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
3. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Protective gene may enhance vaccine responses
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. New glycan arrays discover autoimmunogenic activities of SARS-CoV: concern over monkey vaccine
8. Growing new breed of vaccine-producing plants to fight human diseases worldwide
9. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
10. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
11. Herpes tool allows researchers to customize Alzheimers vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
Breaking Biology Technology:
Cached News: